Baldane, S. Et Al. 2018. Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes. Bratislava Medical Journal , vol.119, no.2 , 112-115.

Baldane, S., Ipekci, S., Ekin, A., Abusoglu, S., Unlu, A., & Kebapcilar, L., (2018). Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes. Bratislava Medical Journal , vol.119, no.2, 112-115.

Baldane, S. Et Al. "Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes," Bratislava Medical Journal , vol.119, no.2, 112-115, 2018

Baldane, S. Et Al. "Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes." Bratislava Medical Journal , vol.119, no.2, pp.112-115, 2018

Baldane, S. Et Al. (2018) . "Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes." Bratislava Medical Journal , vol.119, no.2, pp.112-115.

@article{article, author={S. Baldane Et Al. }, title={Evaluation of fractalkine (FKN) and secreted frizzled-related protein 4 (SFRP-4) serum levels in patients with prediabetes and type 2 diabetes}, journal={Bratislava Medical Journal}, year=2018, pages={112-115} }